The effectiveness of Comirnata is declining faster than Vaxzevria – SME.sk

LONDON. Efficiency vaccines Comirnaty from the Pfizer / BioNTech consortium is declining faster than the efficacy of Vaxzevria from AstraZeneca.

In a new study, this is stated by researchers from Oxford University, who published the document on Thursday. The Guardian reported.

“Two doses of Pfizer / BioNTech have a higher initial effectiveness in preventing infection, but the effectiveness (of the vaccine) decreases faster compared to two doses of AstraZeneca,” the researchers said.

Related article A comprehensive review of Covid-19 vaccines: Efficacy, side effects and doses Read

The Guardian noted that the study, which has not yet been reviewed, is based on the results of a survey by the British Bureau of National Statistics, which tested citizens in PCR randomly from December to August. More than 300,000 citizens over the age of 18 were involved in the survey.

“The results suggest that four to five months after the second dose, the effectiveness of both types of vaccines is similar,” said the study’s authors, adding that the vaccines provided greater protection for those who had previously COVID-19.

For completeness, the British daily reported that a scientific group from Oxford University (Oxford Vaccine Group) was involved in the development of a vaccine for AstraZeneca.

All about coronavirus and COVID-19